Intelligent Bio Solutions Inc.
INBS
$1.41
$0.129.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.54M | -2.25M | -2.69M | -2.78M | -2.98M |
| Total Depreciation and Amortization | 296.80K | 307.60K | 303.10K | 287.70K | 327.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -900.00 | 56.00K | 73.70K | 82.70K | 174.20K |
| Change in Net Operating Assets | -507.80K | -438.90K | -78.40K | -530.20K | 29.40K |
| Cash from Operations | -2.76M | -2.32M | -2.39M | -2.94M | -2.45M |
| Capital Expenditure | -14.40K | -8.90K | -- | -167.30K | 2.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -14.40K | -8.90K | -- | -167.30K | 2.60K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.30M | 652.40K | 42.50K | 5.30K | 13.21M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -3.04M |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 20.60K | -20.60K | -- | -- | 592.40K |
| Cash from Financing | 3.32M | 631.70K | 42.50K | 5.30K | 10.77M |
| Foreign Exchange rate Adjustments | 13.10K | -45.30K | 30.10K | 12.60K | -46.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 564.90K | -1.75M | -2.31M | -3.09M | 8.28M |